Market Overview:
The United States transfection technologies market size reached US$ 386.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 700.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 386.3 Million |
Market Forecast in 2032
|
US$ 700.7 Million |
Market Growth Rate (2024-2032) |
6.63% |
Transfection technology is the process of artificially introducing nucleic acids like Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) and oligonucleotides into the eukaryotic cells. It can be introduced using physical, biological and chemical methods, which help in modifying certain properties of the cell. It includes cationic lipid transfection, electroporation, transfection and in-vivo transfection. At present, it is widely utilized for genomic studies that include screening, gene expression, Vivo research and RNA interference in the United States.
The transfection technologies market in the US is mainly driven by the rising cases of infectious diseases that require antibiotics. Additionally, the growing utilization of cell-based products is catalyzing the demand for transfection methods to treat chronic diseases, such as tuberculosis, cancer, and cardiovascular diseases in the US. Apart from this, reagent-based transfection technology is significantly expanding due to its cost-effectiveness and accuracy. It includes biolistic technology, laserfection and microinjection, which is impelling the growth of the market in the country. Besides this, the leading manufacturers are focusing on investing in the research and development (R&D) of cancer therapeutics, advanced cytological studies and precision medicine, which is creating a positive outlook for the market growth. Furthermore, growing investments by both governing and private organizations to develop large-scale transfection facilities and extensive research and development (R&D) activities in the field of protein therapeutics are driving the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the United States transfection technologies market report, along with forecasts at the country and regional levels from 2024-2032. Our report has categorized the market based on product type, application, transfection method, technology and end user.
Breakup by Product Type:
- Reagent
- Instrument
- Others
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
- Others
Breakup by Transfection Method:
- Lipofection
- Electroporation
- Nucleofection
- Cotransfection
- Cationic Lipid Transfection
- In-Vivo Transfection
- Others
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Product Type, Application, Transfection Method, Technology, End User, Region |
Region Covered |
Northeast, Midwest, South, West |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the United States transfection technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the United States transfection technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the transfection method?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What is the breakup of the market based on the transfection method?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the United States transfection technologies market and who are the key players?
- What is the degree of competition in the industry?